SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-23-096065 from Armlogi Holding Corp. (BTOC) (CIK 0001972529) (BTOC)

Armlogi Holding Corp. (BTOC) (CIK 0001972529)
Date: Dec. 15, 2023 · CIK: 0001972529 · Accession: 0001213900-23-096065

AI Filing Summary & Sentiment

File numbers found in text: 333-274667

Referenced dates: November 21, 2023

Date
December 15, 2023
Author
/s/ Aidy Chou
Form
CORRESP
Company
Armlogi Holding Corp. (BTOC) (CIK 0001972529)

Letter

ARMLOGI HOLDING CORP.

December 15, 2023

Via EDGAR

Division of Corporation Finance

Office of Energy & Transportation

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

Attention: Joanna Lam

Raj Rajan

Michael Purcell

Kevin Dougherty

Re: Armlogi Holding Corp.

Amendment No. 1 to Registration Statement on Form S-1

Filed November 9, 2023

File No. 333-274667

Ladies and Gentlemen:

This letter is in response to the letter dated November 21, 2023, from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) addressed to Armlogi Holding Corp. (the “Company,” “we,” and “our”). For ease of reference, we have recited the Commission’s comment in this response. An amended Registration Statement on Form S-1 (the “Amended Registration Statement No. 2”) is being filed to accompany this letter.

Cover Page

1. We note you disclose that the Representative’s Warrants are exercisable during the five year period from the commencement of sales of the offering, which appears consistent with Section 2(g) of your Form of Underwriting Agreement filed as Exhibit 1.1. However, you disclose on page 75, in your Fee Table Exhibit, and in your Form of Representative’s Warrant Agreement attached as Exhibit B to your underwriting agreement, that the Warrants have an initial exercise date beginning from six months following the date of the commencement of sales of this offering. Please revise to clarify these conflicting disclosures and consistently disclose the initial exercise date.

In response to the Staff’s comments, we revised our disclosure on page 80 of the Amended Registration Statement No. 2, our Fee Table Exhibit, and our Form of Representative’s Warrant Agreement, to clarify that the Representative’s Warrants are exercisable during the five-year period from the commencement of sales of the offering.

We appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Ying Li, Esq., of Hunter Taubman Fischer & Li LLC, at (212) 530-2206.

Very truly yours,
/s/ Aidy Chou

Show Raw Text
CORRESP
1
filename1.htm

ARMLOGI HOLDING CORP.

December 15, 2023

Via EDGAR

Division of Corporation Finance

Office of Energy & Transportation

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

    Attention:
    Joanna Lam

    Raj Rajan

    Michael Purcell

    Kevin Dougherty

    Re:
    Armlogi Holding Corp.

    Amendment No. 1 to Registration Statement on Form S-1

    Filed November 9, 2023

    File No. 333-274667

Ladies and Gentlemen:

This letter is in response to the letter dated
November 21, 2023, from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”)
addressed to Armlogi Holding Corp. (the “Company,” “we,” and “our”). For ease of reference, we have
recited the Commission’s comment in this response. An amended Registration Statement on Form S-1 (the “Amended Registration
Statement No. 2”) is being filed to accompany this letter.

Cover Page

1. We note you disclose that the
Representative’s Warrants are exercisable during the five year period from the commencement of sales of the offering, which appears consistent
with Section 2(g) of your Form of Underwriting Agreement filed as Exhibit 1.1. However, you disclose on page 75, in your Fee Table Exhibit,
and in your Form of Representative’s Warrant Agreement attached as Exhibit B to your underwriting agreement, that the Warrants have
an initial exercise date beginning from six months following the date of the commencement of sales of this offering. Please revise to
clarify these conflicting disclosures and consistently disclose the initial exercise date.

In response to the Staff’s comments, we
revised our disclosure on page 80 of the Amended Registration Statement No. 2, our Fee Table Exhibit, and our Form of Representative’s
Warrant Agreement, to clarify that the Representative’s Warrants are exercisable during the five-year period from the commencement
of sales of the offering.

We appreciate the assistance the Staff has provided
with its comments. If you have any questions, please do not hesitate to call our counsel, Ying Li, Esq., of Hunter Taubman Fischer &
Li LLC, at (212) 530-2206.

Very truly yours,

    /s/ Aidy Chou

    Name:
     Aidy Chou

    Title:
    Chief Executive Officer

    cc:
    Ying Li, Esq.

    Hunter Taubman Fischer & Li LLC